Diagnostic Challenges of Early T-cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Nov 18

PMID 39553118

Authors

Mohammed Bensalah

Abdelilah Berhili

Mounia Slaoui

Assya Khermach

Rachid Seddik

Affiliations

Soon will be listed here.

Abstract

Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is an uncommon subtype of T-cell acute lymphoblastic leukemia (T-ALL), constituting approximately 10-13% of T-ALL cases in childhood and 5-10% in adults. A 55-year-old female patient presented with no significant medical history and was hospitalized in the internal medicine department due to anemia and deterioration of her overall health. The clinical examination did not reveal any tumor syndrome. A complete blood count was performed showing normocytic normochromic anemia with leukocytosis. The myelogram revealed bone marrow invasion by blasts of 80%. Immunophenotyping revealed the presence of a blast population of T lymphoid nature estimated at 74% of the marrow elements with a particular immunophenotype. Thus, the diagnosis of ETP-ALL was retained. A karyotype was carried out showing the presence of a hypotetraploid clone with clonal anomalies in number and structure. The patient was put on hyper-CVAD protocol (cyclophosphamide, doxorubicine, vincristine, dexamethasone). A myelogram at the end of induction revealed the presence of 45% blasts. The categorization of ETP-ALL as a distinct entity in the WHO classification arises from its distinguishable phenotypic and genetic characteristics. However, the diagnosis and management of ETP-ALL always constitutes a challenge for the biologist and clinician. Therefore, it is essential to conduct more extensive studies for a better comprehension of the clinical and biological features of ETP-ALL, specifically focusing on its genetic nuances.

References

Dworzak M, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D . AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom. 2017; 94(1):82-93. DOI: 10.1002/cyto.b.21518. View

Sin C, Man P . Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies. Front Oncol. 2021; 11:750789. PMC: 8666570. DOI: 10.3389/fonc.2021.750789. View

Khurana S, Melody M, Ketterling R, Peterson J, Luoma I, Vazmatzis G . Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens. Cancer Genet. 2019; 240:40-44. DOI: 10.1016/j.cancergen.2019.11.002. View

Tarantini F, Cumbo C, Anelli L, Zagaria A, Specchia G, Musto P . Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick. Biomark Res. 2021; 9(1):89. PMC: 8686563. DOI: 10.1186/s40364-021-00347-z. View

Porwit A, Bene M . Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia. Cytometry B Clin Cytom. 2019; 96(3):183-194. DOI: 10.1002/cyto.b.21783. View

Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P . T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. Genes (Basel). 2021; 12(8). PMC: 8394887. DOI: 10.3390/genes12081118. View

Genesca E, La Starza R . Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets. Cancers (Basel). 2022; 14(8). PMC: 9030030. DOI: 10.3390/cancers14081873. View

Zhang J, Ding L, Holmfeldt L, Wu G, Heatley S, Payne-Turner D . The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012; 481(7380):157-63. PMC: 3267575. DOI: 10.1038/nature10725. View

Bene M, Castoldi G, Knapp W, Ludwig W, Matutes E, Orfao A . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995; 9(10):1783-6. View

10.

Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719. PMC: 9252913. DOI: 10.1038/s41375-022-01613-1. View

11.

Angelova E, Audette C, Kovtun Y, Daver N, Wang S, Pierce S . CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia. Haematologica. 2018; 104(4):749-755. PMC: 6442980. DOI: 10.3324/haematol.2018.205252. View

12.

Liu S, Cui Q, Dai H, Song B, Cui W, Xue S . Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2021; 27(6):481.e1-481.e7. DOI: 10.1016/j.jtct.2021.02.032. View

13.

Castaneda Puglianini O, Papadantonakis N . Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts. Ther Adv Hematol. 2020; 11:2040620720929475. PMC: 7370557. DOI: 10.1177/2040620720929475. View

14.

Coustan-Smith E, Mullighan C, Onciu M, Behm F, Raimondi S, Pei D . Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009; 10(2):147-56. PMC: 2840241. DOI: 10.1016/S1470-2045(08)70314-0. View

15.

Inukai T, Kiyokawa N, Campana D, Coustan-Smith E, Kikuchi A, Kobayashi M . Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15. Br J Haematol. 2011; 156(3):358-65. DOI: 10.1111/j.1365-2141.2011.08955.x. View

16.

Lato M, Przysucha A, Grosman S, Zawitkowska J, Lejman M . The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci. 2021; 22(9). PMC: 8123476. DOI: 10.3390/ijms22094502. View

17.

Jain N, Lamb A, OBrien S, Ravandi F, Konopleva M, Jabbour E . Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016; 127(15):1863-9. PMC: 4915808. DOI: 10.1182/blood-2015-08-661702. View